Aprogen Medicines Inc. (KRX:007460)

Aprogen Medicines Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	39,625	37,162	35,684	43,070	15,894	96,616
Short-Term Investments	-	-	-	-	4,000	-
Trading Asset Securities	4,000	6,500	5,000	4,390	-	140,847
Cash & Short-Term Investments	43,625	43,662	40,684	47,460	19,894	237,463
Cash Growth	32.50%	7.32%	-14.28%	138.57%	-91.62%	35.80%
Accounts Receivable	18,953	19,674	24,809	21,389	1,567	21,364
Other Receivables	2,115	1,170	1,607	7,988	9,759	5,682
Receivables	24,361	24,356	34,637	92,306	56,990	176,693
Inventory	59,165	62,483	60,815	61,467	23,257	17,302
Prepaid Expenses	1,104	967.42	847.35	913.48	906.58	135.72
Other Current Assets	4,089	2,849	7,224	9,432	2,052	2,911
Total Current Assets	132,344	134,317	144,207	211,578	103,099	434,504
Property, Plant & Equipment	360,616	364,181	362,959	365,100	314,479	40,186
Long-Term Investments	82,232	9,790	2,447	3,298	54,786	183,574
Goodwill	-	-	-	-	-	9.62
Other Intangible Assets	5,726	6,106	7,489	8,431	2,633	3,355
Long-Term Accounts Receivable	-	-	-	-	-	21,698
Long-Term Deferred Tax Assets	-	-	-	662.84	-	2,789
Long-Term Deferred Charges	50,698	46,601	34,625	4,988	-	478
Other Long-Term Assets	1,113	3,902	1,224	5,222	1,904	28,206
Total Assets	673,171	609,968	594,428	599,853	477,646	834,308
Accounts Payable	2,455	3,423	2,734	4,186	3,920	1,421
Accrued Expenses	2,593	2,683	2,556	4,117	8,410	1,092
Short-Term Debt	46,219	35,784	46,631	49,763	398,613	58,600
Current Portion of Long-Term Debt	45,000	45,000	44,938	7,675	-	-
Current Portion of Leases	575.65	592.23	560.08	934.88	2,785	392.95
Current Income Taxes Payable	160.62	246.72	-	4.18	-	874.11
Current Unearned Revenue	-	-	-	-	-	152.34
Other Current Liabilities	101,422	25,231	28,222	23,253	8,202	22,562
Total Current Liabilities	198,425	112,959	125,640	89,933	421,929	85,094
Long-Term Debt	32,000	32,000	32,000	31,251	31,046	26,335
Long-Term Leases	260.65	326.69	288.35	571.03	19,925	325.92
Long-Term Deferred Tax Liabilities	6,590	6,590	5,375	5,322	1,167	-
Other Long-Term Liabilities	2,365	2,308	1,696	1,455	309.39	26,315
Total Liabilities	257,047	169,878	176,740	138,851	478,453	144,269
Common Stock	155,913	152,062	132,419	126,834	260,351	91,473
Additional Paid-In Capital	516,836	512,886	472,949	431,641	46,794	347,601
Retained Earnings	-433,299	-417,299	-358,604	-293,691	-192,837	-85,366
Treasury Stock	-98,115	-98,115	-98,115	-98,084	-	-3.6
Comprehensive Income & Other	7,469	9,099	-849.67	48,392	-112,146	-34,727
Total Common Equity	148,805	158,634	147,800	215,092	2,163	318,978
Minority Interest	267,319	281,457	269,888	245,910	-2,970	371,062
Shareholders' Equity	416,124	440,091	417,688	461,002	-806.44	690,040
Total Liabilities & Equity	673,171	609,968	594,428	599,853	477,646	834,308
Total Debt	124,055	113,702	124,417	90,195	452,369	85,654
Net Cash (Debt)	-80,431	-70,041	-83,732	-42,736	-432,475	151,809
Net Cash Growth	-	-	-	-	-	68.85%
Net Cash Per Share	-298.23	-271.08	-354.54	-211.16	-2494.46	2684.94
Filing Date Shares Outstanding	291.07	283.37	244.08	232.93	66.38	60.98
Total Common Shares Outstanding	291.07	283.37	244.08	232.93	66.38	60.98
Working Capital	-66,081	21,357	18,567	121,644	-318,829	349,410
Book Value Per Share	511.24	559.82	605.54	923.42	32.59	5230.74
Tangible Book Value	143,080	152,528	140,311	206,661	-469.92	315,614
Tangible Book Value Per Share	491.57	538.27	574.86	887.23	-7.08	5175.57
Land	50,012	50,012	44,136	44,190	12,484	13,628
Buildings	115,772	115,772	115,622	113,611	88,041	21,159
Machinery	258,569	258,162	195,122	191,265	137,051	27,204
Construction In Progress	62,820	61,140	107,580	88,234	85,017	1,414

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.